The Buy vs. Build Decision: Choosing the Right Patient Access Program Strategy for Your Medical Technology
The promise of an in-house patient access program is compelling: greater control, deeper provider relationships, and a direct hand in getting patients to therapy faster. But the path from vision to execution is lined with decisions that can make or break the effort. We offer some suggestions for consideration based on our experience. For medical […]
Two Systemic Barriers Blocking Access to Cutting-Edge Medical Technologies
Medical innovation outpaces medical policy with health insurance plans. That reality can be difficult to accept for companies that have poured significant investment into a new device, drug, or biologic. For health plans, FDA marketing authorization is important, but other factors are essential: long-term data, medical society guidelines, provider utilization, etc. Until those factors are […]
Why Your Medical Device Needs a Patient Access Program
You’ve done the hard work. Your medical device has FDA clearance or approval. Clinical data supports its efficacy. Providers are interested. And yet, patients are being denied coverage and adoption is stalling. Two of the most common and misunderstood barriers in medical device market access are silent medical policy (no policy on file) and Experimental […]